Could a vaccine made from your own tumor stop colon cancer from returning?

NCT ID NCT02448173

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tests a personalized cancer vaccine called OncoVAX for people with Stage II colon cancer. After surgery to remove the tumor, the patient's own cancer cells are used to create a vaccine that trains the immune system to attack any remaining cancer cells. The goal is to prevent the cancer from coming back. The study will enroll about 550 participants and compare disease-free survival between those who receive the vaccine plus surgery versus surgery alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

OncoVAX (personalized cancer vaccine made from the patient's own tumor cells)

What this could lead to

If it works, this could offer a way to prevent colon cancer from coming back after surgery, potentially reducing the need for chemotherapy in some patients.

What could go wrong

This is still experimental and in a large Phase 3 trial, so results are not guaranteed. The vaccine is custom-made for each patient, which is complex, and it may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE II COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colon carcinoma colonic neoplasm malignant colon neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Halifax Health Medical Center

    Port Orange, Florida, 32127, United States

    Contact

    Contact